In our ongoing search for anti-inflammatory and neuroprotective agents of natural origin, the total methanolic extract (MPE) of horse apple (Maclura pomifera) and its two major prenylated isoflavones, osajin (OSA) and pomiferin (POM), were evaluated in vitro for their ability to affect four mediators of inflammation and to inhibit tau protein fibrillization. The two isoflavones were effective in enhancing the activity of NSAID activated gene (NAG-1) at 2.5 g/mL (1.5 -1.8 fold increase) and inhibiting iNOS and NF-B activity with IC 50 values in the range of 6 -13 µg/mL. Pomiferin also inhibited intracellular oxidative stress with IC 50 of 3.3 µg/mL, while osajin did not show any effect. The extract activated NAG-1 and inhibited iNOS and oxidative stress without affecting NF-B. As observed by transmission electron microscopy (TEM), MPE, OSA and POM also inhibited arachidonic acid-induced tau fibrillization in a concentration-dependent manner.
The fruit of Maclura pomifera (Raf.) Schneid. (Moraceae), also known as horse apple or osage orange [1, 2] , is an herbal entity abundant in the Midwest and Southern United States. Due to its abundance, horse apple may provide a sustainable source for bioactive natural products. However, mature horse apple fruits are often wasted when they fall off the trees and are scattered on roads and sidewalks during the fall season. If properly utilized, horse apple can provide high yields of prenylated isoflavones, mainly osajin (OSA) and pomiferin (POM) ( Figure 1 ) as promising candidates for drug discovery efforts [3] . Many flavonoid compounds have displayed antioxidant and anti-inflammatory activities that may be beneficial in various disease conditions [4] [5] [6] . Soy isoflavones genistein and daidzein were also reported to inhibit tau hyperphosphorylation, a key step in tau protein fibrillization, one of the characteristic features of many neurodegenerative disorders, such as Alzheimer's disease (AD) [7] . Tau protein deposition leads to a cascade of local inflammatory reactions that further contribute to the pathology of AD and the rapid progression of its symptoms [8] . Numerous plant secondary metabolites and herbal medicines have been investigated for their efficacy against AD pathologies [9, 10] . Of these, polyphenolic compounds, such as curcuminoids and flavonoids, are among the most promising by acting as antioxidants, anti-inflammatory, and protein fibrillization inhibitors [11, 12] . Other classes of natural products, such as alkaloids and terpenoids, and herbal entities, such as ginkgo and ginseng, are also promising candidates [9] . Thus, the total extract (MPE) of horse apple fruit and its two major isoflavones (OSA & POM) were subjected to a preliminary evaluation to determine their effects on a number of inflammation-associated targets, mainly reactive oxygen species (ROS), nitric oxide synthase (iNOS), nuclear factor B (NF-B) and NSAID activated gene (NAG-1) as well as tau fibrillization. Our results show that horse apple constituents are promising inhibitors of tau fibrillization and inhibitors of iNOS and NF-B, along with the property of NAG-1 activation similar to NSAIDs. Thus, they could serve as potential candidates for further investigation in inflammatory conditions and/or neurodegenerative disorders. HPLC analysis of MPE showed the presence of OSA and POM as its major constituents [3] . Both isoflavones were isolated in a pure form as yellow (OSA, 66 mg) and orange (POM, 60 mg) powders from the total extract by flash chromatography. NMR and mass spectral characteristics of purified OSA and POM were in agreement with the literature [1] . Thus, samples for biological evaluation included MPE, OSA and POM.
When evaluated for its inhibition of iNOS activity in LPS-induced macrophages and ROS generation in PMA-induced HL-60 cells, MPE was found to be moderately active with IC 50 values in the range of 10-23 µg/mL. The extract did not show any inhibition of PMA-induced NF-B activity in chondrocytes (SW1353). The extract (50 µg/mL) also showed a significant induction of NAG-1 activity (2.4 fold), which is similar to the action of NSAIDs such as diclofenac (Table1). The two isoflavones (OSA and POM) showed inhibition of NF-B with IC 50 values of 12 and 13 µg/mL and inhibition of iNOS activity with IC 50 values of 7.2 and 6.4 µg/mL, respectively. Inhibition of NF-B was specific and not due to general cytotoxicity (IC 50 for control transcription factor Sp-1 was >25 µg/mL for both isoflavones). POM inhibited intracellular oxidative stress by decreasing ROS generation in PMA-induced HL-60 cells with an IC 50 value of 3.3 µg/mL, while no such effect was seen in response to OSA. However, both compounds were still less active than positive controls by 3-10 fold ( Table 1 ). It was interesting to note that all samples were more promising in activating NAG-1 whereby MPE (at 50 g/mL) and its major constituents (OSA & POM at 6.0 M) resulted in fold inductions (1.5 -2.4 fold) that were comparable with diclofenac (1.8 fold at 20 M)( Table 1) . No cytotoxicity was observed towards HL-60 cells in the ROS inhibition assay (Data not shown). As reported earlier and recently demonstrated by our lab, the fruit of M. pomifera is rich in the two isoflavones osajin and pomiferin [3] . As such, it can provide a renewable source for these secondary metabolites and allows for a thorough investigation of their biological activities and subsequent chemical optimization. As natural polyphenols, it was rational to investigate OSA and POM for certain activities that are common to this class of natural products, mainly antioxidant and anti-inflammatory activities, with focus on specific types of molecular targets. Also, the fact that other phytoestrogenic isoflavones were reported to inhibit tau fibrillization provided another target to direct our bio-evaluation of the two compounds and to converge our findings towards AD as a pathological condition that involves both inflammation and tau protein fibrillization.
The anti-inflammatory activity of MPE, OSA and POM was evaluated in terms of their ability to inhibit NF-B and iNOS activity, to decrease oxidative stress and to induce NAG-1 activity through a panel of four in vitro cell based assays. NF-B, iNOS and NAG-1 are considered significant targets involved in the progress of inflammatory conditions. Cellular oxidative stress due to increased level of ROS also plays an important role in the process of inflammation and resulting degenerative conditions. Both OSA and POM inhibited NF-B transcriptional activity in PMA-induced cells as determined by a reporter gene assay. Inclusion of the Sp-1 control transcription factor showed that the inhibitory effect was specific for NF-B and was not due to a general cytotoxic effect. Interestingly, MPE did not inhibit NF-B activity in spite of its rich content of both isoflavones. This may be attributed to the presence of other constituents in the extract that may antagonize the NF-kB inhibitory activity of the two isoflavones. The inhibition of iNOS activity was also seen in LPS-induced macrophages resulting into a decreased production of nitrites, as determined by Griess reagent. Increased activity of iNOS in response to proinflammatory signals leads to the accumulation of reactive nitrogen species (RNS) as a result of increased NO production. One of the isoflavones (POM) was also found to decrease oxidative stress by inhibiting the intracellular generation of ROS in response to PMA in HL-60 cells. Evidence exists that one or both act as antioxidants by other mechanisms. For example, POM has been reported to possess strong in vitro antioxidant activity as a scavenger of peroxynitrite and DPPH free radical and inhibitor of lipid peroxidation [13] . Both isoflavones were also reported to act as cardioprotective agents in vivo by enhancing total antioxidant capacity and elevating antioxidant enzyme levels in isolated rat hearts [14] . The NAG-1 gene has recently been identified as a target for anti-inflammatory and anticancer therapy, especially for NSAIDs. A number of natural products have already been reported to induce NAG-1 activity, including the isoflavone genistein [15, 16] . The fact that both compounds (OSA and POM) showed activities that were comparable with the positive control (diclofenac at 20 M) further demonstrates the potential of developing isoflavones as antiinflammatory agents targeting NAG-1. The antioxidant and NAG-1 induction activity of MPE could be explained due to the presence of these isoflavones.
The other target for biological evaluation was tau-protein, which is one of the pathological features of neurodegenerative disorders. The rationale for pursuing this target was discussed in the introduction. Although activity was evaluated in tau fibrillization inhibition assay only, our qualitative preliminary results observed by visual inspection of TEM imaging indicate that all samples resulted in either reduction or complete inhibition of tau filaments formation at various concentrations with POM being the most active. The observed inhibitory concentrations were comparable with those of previously reported tau fibrillization inhibitors [12, [17] [18] [19] . Further evaluation against this target is thus warranted.
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In conclusion, a common challenge in natural products drug discovery is the need to process significant amounts of the crude plants or to resort to chemical synthesis to secure supply of active constituents that exist at low concentrations in plant material. This can lead to delays in the development of potential candidates or even to cancellation of whole projects. Fortunately, supply is not an issue with horse apple due to the abundance of the crude plant material and the significantly high levels of OSA and POM present in the fruit. Due to their demonstrated activities presented in this work and supported by related antioxidant activities reported by others, both compounds may be considered as potential candidates for further investigation against AD and other neurodegenerative disorders. Studies to explore the activity of OSA and POM in neuronal cells, such as microglial/astroglial cell lines, as well as animal models of AD is thus warranted. Additionally, the activity demonstrated by horse apple extract may support its introduction as a beneficial dietary supplement. The horse apple tree should also be propagated as a sustainable economic source for bioactive natural products.
Experimental

Preparation of herbal extract and pure compounds:
Whole mature fallen horse apple fruits (Maclura pomifera (Raf.) Schneid., family: Moraceae) were collected from the sidewalk in Frankfort, IL, during October 2011. The samples were identified by one of the authors (E.A. Abourashed) and a fresh specimen was stored at -20 o C at the Chicago State University College of Pharmacy (voucher specimen no.: COP-101). The fruits were sliced, oven-dried for 48 h at 80 o C, and ground to a fine powder. A total extract was prepared by ultrasonicating an aliquot of the powder (5.0 g) for 30 min in methanol (50 mL), followed by filtration and concentrating the filtrate at 45 o C under vacuum to a brownish semisolid residue (MPE, 280 mg). The dry extract (MPE) was fingerprinted and its two major isoflavones quantified by an in-house HPLC method [3] . The major isoflavones, osajin (OSA) and pomiferin (POM), were isolated from a separate aliquot of MPE by flash chromatography (Isolera 1 ® , Biotage, Uppsala, Sweden) on a silica gel cartridge (50 g) with the following settings: sample application MPE (250 mg) dissolved in 2 mL methanol, applied to a 3 g samplet cartridge (Biotage) and dried at room temperature with an air gun for 5 min; gradient 7-60% ethyl acetate in n-hexane; flow rate 50 mL/min; fraction volume 22 mL; total fractions 40; detection 270 nm. Fractions containing similar compounds were pooled and dried in a rotary evaporator at 45 o C to yield pure OSA and POM (66 & 60 mg, respectively, >98% for both). Purity of the isolated compounds was confirmed by HPLC and NMR spectroscopy (ECS-400 spectrometer, JEOL, Japan). All chemicals and reagents were of either analytical or spectroscopic grade as required and were purchased as mentioned in their respective sections.
Assay for antioxidant activity Inhibition of reactive oxygen species (ROS) generation:
Antioxidant activity was determined in terms of the inhibition of intracellular generation of reactive oxygen species (ROS) in myelomonocytic cells (HL-60) by the 2',7'dichlorodihydrofluorescein diacetate (DCFH-DA) method, as described earlier [20] . HL-60 cells (ATCC) were cultured in RPMI 1640 medium with 10% FBS and antibiotics. For the assay, cells were added to a 96-well plate (100,000 cells/well). After treatment with test compounds for 30 min, cells were stimulated with 100 ng/mL phorbol 12-myristate-13-acetate (PMA, Sigma) for 30 min. DCFH-DA (Molecular Probes, 5 µg/mL) was added and cells were further incubated for 15 min. Levels of DCF produced were measured on a Spectramax plate reader with an excitation wavelength of 485 nm and emission of 530 nm. The percent decrease in DCF production in response to MPE, OSA and POM was calculated compared with the vehicle control. The IC 50 values were obtained from dose curves. Trolox (>98%, Sigma-Aldrich) was used as positive control. Cytotoxicity to HL-60 cells was also determined after incubating the cells (2 x 10 4 cells/well in 225 µL) with test samples for 48 h by the XTT method, as described earlier [21] .
Assay for inhibition of iNOS activity:
The assay [22] was performed in mouse macrophages (RAW264.7) cultured in phenol red free RPMI medium with 10% bovine calf serum and 100 U/mL penicillin G sodium, and 100 µg/mL streptomycin. Cells were seeded in 96-well plates (50, 000 cells/well) and incubated for 24 h for a confluency of 75% or more. Test samples diluted in serum free medium were added and after 30 min of incubation, lipopolysaccharides (LPS, 5 µg/mL) were added and cells were further incubated for 24 h. The concentration of nitric oxide (NO) was determined by measuring the level of nitrite in the cell culture supernatant by using Griess reagent. Percent inhibition of nitrite production by MPE, OSA and POM was calculated in comparison with vehicle control. IC 50 values were obtained from dose curves. Parthenolide (>90%, Sigma-Aldrich) was used as positive control.
Reporter gene assay for inhibition of NF-B activity:
The assay [23] was performed in human chondrosarcoma (SW1353) cells cultured in a 1:1 mixture of DMEM/F12 supplemented with 10% FBS, 100 U/mL penicillin G sodium, and 100 µg/mL streptomycin. Cells (1.2 × 10 7 ) were washed once in an antibiotic and FBS-free DMEM/F12, and then resuspended in 500 µL of antibiotic-free DMEM/F12 containing 2.5% FBS. NF-B luciferase plasmid construct was added to the cell suspension at a concentration of 50 µg/mL and incubated for 5 min at room temperature. The cells were electroporated at 160 V and one 70-ms pulse using BTX disposable cuvettes model 640 (4-mm gap) in a BTX Electro Square Porator T 820 (BTX I). After electroporation, 1.25 × 10 5 cells per well were plated in 200 µL of DMEM/F12 containing 10% FBS and antibiotics. After 24 h, cells were treated with different concentrations of test compounds for 30 min and then induced with PMA (70 ng/mL) for 8 h. Luciferase activity was measured using a luciferase assay kit (Promega). Light output was detected on a SpectraMax plate reader. Percent inhibition of NF-B activity by MPE, OSA and POM was calculated compared with vehicle control. Parthenolide was included as positive control. Sp-1 was used as a control transcription factor in parallel to NF-B.
Reporter gene assay for the activation of NAG-1:
The assay [23] was performed in human chondrosarcoma (SW1353) cells cultured as above. For the assay, cells were transfected with 25 μg of NAG-1 luciferase plasmid construct containing a full-length NAG-1 cDNA (a gift from Dr Thomas E. Eling, NIH, Research Triangle Park, NC, USA) by electroporation at 160 V and one 70 ms pulse using a BTX Electro Square Porator T 820 (BTX I, San Diego, CA, USA). Transfected cells were plated in 96-well plates at 1 × 10 5 cells/200 μL/well in DMEM/F12 supplemented with 10% FBS. After 24 h, the cells were treated with different concentrations of test compounds for 24 h. Luciferase activity was measured using a luciferase assay kit (Promega, Madison, WI, USA). Light output was detected on a SpectraMax plate reader. Fold induction in NAG-1 activity in response to MPE, OSA and POM was calculated in comparison with vehicle control. Diclofenac (>98%, Sigma-Aldrich) was used as a positive control.
